Repurposing the Ionophore, PBT2, for Treatment of Multidrug-Resistant Neisseria gonorrhoeae Infections.


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
20 09 2022
Historique:
pubmed: 19 8 2022
medline: 24 9 2022
entrez: 18 8 2022
Statut: ppublish

Résumé

Multidrug-resistant (MDR) N. gonorrhoeae is a current public health threat. New therapies are urgently needed. PBT2 is an ionophore that disrupts metal homeostasis. PBT2 administered with zinc is shown to reverse resistance to antibiotics in several bacterial pathogens. Here we show that both N. meningitidis and MDR N. gonorrhoeae are sensitive to killing by PBT2 alone. PBT2 is, thus, a candidate therapeutic for MDR N. gonorrhoeae infections.

Identifiants

pubmed: 35980187
doi: 10.1128/aac.02318-21
pmc: PMC9487457
doi:

Substances chimiques

Anti-Bacterial Agents 0
Ionophores 0
Zinc J41CSQ7QDS

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0231821

Références

Lancet Neurol. 2015 Jan;14(1):39-47
pubmed: 25467848
Mol Brain. 2019 Dec 9;12(1):106
pubmed: 31818314
Nat Med. 2004 Dec;10(12 Suppl):S122-9
pubmed: 15577930
Microbiol Resour Announc. 2020 May 21;9(21):
pubmed: 32439664
J Bacteriol. 2005 Jun;187(11):3713-20
pubmed: 15901695
Biochem Biophys Res Commun. 2013 Feb 8;431(2):215-20
pubmed: 23313483
MMWR Morb Mortal Wkly Rep. 2020 Jun 19;69(24):735-739
pubmed: 32555137
Inorg Chem. 2020 Dec 7;59(23):17519-17534
pubmed: 33226796
J Antimicrob Chemother. 2009 Jun;63(6):1142-51
pubmed: 19318360
Sci Transl Med. 2020 Nov 18;12(570):
pubmed: 33208501
Lancet Neurol. 2008 Sep;7(9):779-86
pubmed: 18672400
mBio. 2018 Dec 11;9(6):
pubmed: 30538186
Curr Opin Infect Dis. 2010 Dec;23(6):546-53
pubmed: 20802331
Mol Microbiol. 2007 Jan;63(1):54-68
pubmed: 17140413
Mol Microbiol. 2006 Apr;60(2):401-16
pubmed: 16573689
J Antimicrob Chemother. 2021 Oct 11;76(11):2850-2853
pubmed: 34450628
J Proteomics. 2010 Mar 10;73(5):899-916
pubmed: 20004262
J Antimicrob Chemother. 2016 Nov;71(11):3096-3108
pubmed: 27432602
Nat Rev Microbiol. 2011 Nov 02;9(12):894-6
pubmed: 22048738
mBio. 2020 Mar 3;11(2):
pubmed: 32127453
Microbiol Spectr. 2016 Jun;4(3):
pubmed: 27337478
ACS Infect Dis. 2020 Jan 10;6(1):50-55
pubmed: 31697892

Auteurs

Freda E-C Jen (FE)

Institute for Glycomics, Griffith Universitygrid.1022.1, Gold Coast Campus, Queensland, Australia.

Jennifer L Edwards (JL)

The Center for Microbial Pathogenesis, The Abigail Wexner Research Institute at Nationwide Children's Hospital and The Department of Pediatrics, The Ohio State University, Ohio, USA.

Ibrahim M El-Deeb (IM)

Institute for Glycomics, Griffith Universitygrid.1022.1, Gold Coast Campus, Queensland, Australia.

Mark J Walker (MJ)

School of Chemistry and Molecular Biosciences and Australian Infectious Diseases Research Centre, The University of Queenslandgrid.1003.2, Queensland, Australia.

Mark von Itzstein (M)

Institute for Glycomics, Griffith Universitygrid.1022.1, Gold Coast Campus, Queensland, Australia.

Michael P Jennings (MP)

Institute for Glycomics, Griffith Universitygrid.1022.1, Gold Coast Campus, Queensland, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH